The increasing prevalence of gestational diabetes mellitus (GDM) is a pressing global public health concern. Despite extensive identification of GDM risk factors and the implementation of screening programs, there has been a notable lack of significant reduction in maternal, fetal, and neonatal complications. It is vital to recognize that the health trajectory of future generations begins before birth, during intrauterine life and even before conception. The development of 'diabetogenic' and 'obesogenic' changes in the DNA of offspring can be triggered not only by adverse intrauterine conditions, but also by changes in germ cell DNA at earlier stages. Accumulating evidence suggests that the increasing prevalence and persistent metabolic effects of GDM may be mediated by epigenetic modifications. The composition of the human gut microbiota is emerging as a key determinant of human metabolic processes. Consequently, dysbiosis of the gut microbiota via epigenetic mechanisms may contribute to metabolic complications in both the mother and the developing fetus. Given that diet plays a critical role in maintaining a healthy microbiota profile and that certain epigenetic alterations are reversible, it is pertinent to emphasize that not only the pregnant woman but also both partners attempting conception could influence the future health of the child. The aim of this article is to review the role of gut microbiota modulation in preventing and managing gestational diabetes mellitus and the health benefits for mother and child.
9 May 2023 in Journal of Education, Health and Sport
Introduction: An attack of renal colic as a result of kidney stones is one of the most common urological emergencies, with a wide spectrum of severity that generates high morbidity and high health costs. However, there is no single pharmacological treatment regimen for its acute phase. Renal colic is described as one of the worst types of pain, and effective analgesia in the shortest possible time is of paramount importance Aim of the study: Summary of current knowledge on the treatment of Acute renal colic / renal stones. The main purpose of our work is to review and summarize the various recommended options for the treatment of acute renal colic attack and prevention of recurrent urolithiasis depending on the type of stones and also to price the efficacy and safety profile of various drugs used in this ailment and to propose a practical treatment regimen. Material and methods: We conducted a literature search in PubMed using the terms "acute renal colic," "renal colic treatment," "anti-inflammatory drugs," "renal stones," and "fluid therapy." The most relevant clinical trials, meta-analyses and systematic reviews published from January 1, 2017 to January 1, 2022 in English and Spanish were reviewed. Results: In various studies reviewed, non-steroidal anti-inflammatory drugs (NSAIDs) show better pain control, with lower doses and fewer side effects than treatment with opioids. Complete cure in kidney stones is rare due to the frequent recurrence of the disease. Although acute attacks of renal colic are rare in the patients studied, many patients show improvement after taking nonsteroidal anti-inflammatory drugs. Opioids and fluid therapy are reserved for subsequent lines of treatment and also have proven benefits in relieving symptoms.
20 April 2023 in Journal of Education, Health and Sport
Metabolic syndrome (MetS) is metabolic alterations characterised by dysglycemia, raised blood pressure, elevated triglyceride levels, low high-density lipoprotein cholesterol levels, and obesity. It is associated with high morbidity and mortality and the prevalence of it has been increasing in recent years. A significant impact on the risk to develop MetS has dietary habits. Many studies emphasise legume consumption advantages contributing to a decrease of a cluster of metabolic risk factors. The most effective range daily legume consumption is between 55 and 70 g/day. Some varieties of legumes can reform blood pressure by ACE inhibitory activity. Soybean protein hydrolysis showed an advantageous effect on lipid profile by HMGCR inhibitory activity. Legume intake seems to be a valuable predictor of decreasing BMI and abdominal adiposity because of high fibre levels and regulation of adiponectin and 8-epi-PGF2α in obese subjects. Increasing part of legumes as a protein and carbohydrates source in diet, significantly reduces the risk of glucose-insulin homeostasis disorders. Evidently, legumes have comprehensive dietary advantages. However more data and further research on the long-term effects of legumes on metabolic alterations are required to elucidate their effective health implications. Present review is based on articles accessible on pubmed service.
25 April 2023 in Journal of Education, Health and Sport
Diabetes Mellitus is one of the most common civilization diseases.The incidence of this disease has been increasing over the last few decades. Research is still being conducted to show the relationship between diabetes and other diseases. Based on these studies, it can be concluded that it also plays a role in the development of cancer. In this review, we focus on analyzing studies on the relationship between type 2 diabetes and breast cancer. We show the influence of diabetes components on the pathomechanism of breast cancer development. We focus on hyperinsulinemia, inflammatory processes, oxidative stress, and obesity, which often accompany type 2 diabetes. Based on the analyzed studies, it can be concluded that type 2 diabetes is a significant factor contributing to cancerous processes associated with breast cancer. In this review, we used articles available in the PubMed database.
27 May 2023 in Journal of Education, Health and Sport
Introduction and purpose: Lactoferrin (Lf), a glycoprotein found in body fluids, plays a key role in many of the biological mechanisms that occur in the human body. Over the years, more and more studies have contributed to the expansion of the clinical applications of lactoferrin. In this article, we want to focus on using lactoferrin in Neonatology and Obstetrics. The applications of lactoferrin in obstetrics continue to expand, some of which include the prevention of preterm delivery (PTD) and anaemia in pregnant women. Lf also helps to reduce the incidence of necrotizing enterocolitis and sepsis in newborns by mobilising the immune system and participating in the defence against pathogens and has been under investigation as a potential therapeutic agent for genital infections. The aim of this review is to summarise the current state of knowledge, regarding lactoferrin's broad spectrum of action and to highlight its potential therapeutic applications in these contexts. State of knowledge: This article aims to review the current knowledge on the properties of the lactoferrin and its applications in medicine, especially neonatology and obstetrics. Studies available in the PubMed and Google Scholar databases were included in the analysis. Conclusion: While lactoferrin shows promise in improving neonatal and maternal health, additional research is required to fully understand its precise mechanisms of action and optimise its use as a therapeutic agent. There is also a need for further studies to assess the safety and efficacy of lactoferrin in a variety of patient populations. Despite the challenges, lactoferrin continues to be an intriguing subject of scientific research, with potential therapeutic benefits in various medical fields.
29 May 2023 in Journal of Education, Health and Sport
Introduction: Parkinson's disease is one of the most common neurodegenerative disorders, affecting several million people worldwide. In the current diagnosis, the most important thing is to watch for individual symptoms, which appear at different stages of the disease and can worsen over time. The wide variation in symptoms may suggest that they are the result of other diseases. It is a disease with an unknown underlying cause, and is incurable. Aim of the study: Summary of current knowledge regarding diagnosis and treatment of Parkinson's disease. Material and methods: Review of articles from the PubMed database using the following terms: “Parkinson's disease”, “diagnosis”, “treatment”, “genetics”, “levodopa”, ”α-synuclein”. Results: The diagnosis of Parkinson's disease is still based on the clinical picture of the patient. In recent years, research has been underway to develop new biomarkers for the disease that would allow faster detection. The treatment used is based on delaying the progression of the disease and its symptoms. Treatment mainly involves levodopa with carbidopa and drugs to reduce the severity of individual symptoms, in some cases surgical methods are used. Conclusions: Parkinson's disease poses a challenge to doctors because of its unknown cause and incurability. In recent years, a lot of new information has emerged about factors contributing to its onset, such as genetic factors. Treatment, which is mainly based on pharmacotherapy, should be enriched to a greater extent with physical activity adapted by specialists, physiotherapy treatments and also speech exercises, with the aim of making it easier to cope with bothersome symptoms and improve daily life.